DEFZACOTT-6 TAB

DEFZACOTT-6 Tablets 

The photograph shows Defzacott-6 Tablets from Accott Healthcare. The front of the carton clearly states:

Deflazacort Tablets
Defzacott-6

This is a corticosteroid (glucocorticoid) medicine. Unlike the DICLOTT products you showed earlier, this is not an ordinary painkiller.

Composition per tablet

ComponentStrengthTypeMain actionDeflazacort6 mgGlucocorticoid corticosteroidAnti-inflammatory + immunosuppressiveExcipientsq.s.Inactive ingredientsTablet formation/stability

Thus:

Each Defzacott-6 tablet contains Deflazacort 6 mg.

The “-6” in the brand name corresponds to the 6 mg strength.

1. What is Deflazacort?

Deflazacort is a synthetic glucocorticoid corticosteroid.

It belongs to the same broad therapeutic family as drugs such as:

• prednisolone

• prednisone

• methylprednisolone

• dexamethasone

It is not an anabolic steroid.

Its principal effects are:

Anti-inflammatory

↓ inflammation, swelling and inflammatory symptoms

Immunosuppressive

↓ excessive or inappropriate immune-system activity

2. How does Deflazacort work?

Deflazacort enters cells and interacts with the glucocorticoid receptor.

The drug-receptor complex influences gene transcription and alters the production of numerous inflammatory mediators.

In simplified form:

Deflazacort → glucocorticoid receptor → altered gene transcription → ↓ inflammatory mediators → ↓ inflammation

It can reduce inflammatory activity involving:

• cytokines

• inflammatory enzymes

• immune-cell activity

• vascular permeability

• inflammatory signaling molecules

Therefore, its effect is much broader than that of a simple analgesic.

3. What does 6 mg mean?

Deflazacort 6 mg means that each tablet contains 6 mg of the active corticosteroid.

However, 6 mg deflazacort should not be considered equivalent to 6 mg prednisolone.

Deflazacort and prednisolone have different potencies.

As a commonly used approximate clinical comparison:

6 mg deflazacort ≈ 5 mg prednisolone

This is an approximation used for corticosteroid equivalence; the exact clinical conversion depends on the indication, duration and patient.

Do not independently substitute one steroid for another based only on this conversion.

4. What is Defzacott-6 used for?

Deflazacort can be prescribed for conditions in which corticosteroid anti-inflammatory or immunosuppressive activity is required.

Depending on the clinical situation, it may be used in conditions involving:

• severe allergic/inflammatory reactions

• autoimmune diseases

• rheumatological diseases

• inflammatory joint disorders

• certain skin diseases

• inflammatory respiratory conditions

• some neurological/inflammatory conditions

• selected muscular disorders

It has also been used in Duchenne muscular dystrophy (DMD) in appropriate patients.

Important

The appropriate dose varies enormously depending on the disease. A 6-mg tablet does not mean that every condition is treated with one tablet daily.

5. Is it a painkiller?

No.

Deflazacort is not primarily an analgesic.

It can reduce pain indirectly when pain is caused by inflammation.

For example:

Inflammation → swelling/tissue irritation → pain

Deflazacort:

↓ inflammation → ↓ inflammatory pain

But it does not work like:

• paracetamol

• diclofenac

• ibuprofen

6. Important difference from DICLOTT products

You previously showed:

DICLOTT-P

Diclofenac + Paracetamol

DICLOTT-SP

Diclofenac + Paracetamol + Serratiopeptidase

DICLOTT-CP

Diclofenac + Paracetamol + Chlorzoxazone

These are primarily pain/inflammation-oriented combinations.

DEFZACOTT-6

Deflazacort 6 mg

This is a systemic corticosteroid.

It is therefore a substantially different medicine and should not be substituted for diclofenac or routinely combined with it without medical direction.

7. Side effects

The adverse effects of corticosteroids depend heavily on:

• dose

• duration

• frequency

• underlying disease

• patient's age

• other medicines

Short-term effects can include:

• increased appetite

• indigestion

• mood changes

• insomnia

• increased blood glucose

• increased blood pressure

• fluid retention

• stomach discomfort

With prolonged use:

• weight gain

• characteristic changes in body-fat distribution

• osteoporosis

• muscle weakness

• skin thinning

• easy bruising

• impaired wound healing

• cataracts

• glaucoma

• increased susceptibility to infections

• adrenal suppression

• menstrual changes

• metabolic disturbances

Not everyone develops these effects, and risk is strongly related to exposure.

8. Blood sugar

Deflazacort can increase blood glucose.

People with:

• diabetes

• prediabetes

• obesity

• a history of steroid-induced hyperglycemia

may require particular monitoring.

A person taking corticosteroids may notice increased thirst or urination if glucose becomes significantly elevated.

9. Infection risk

Because corticosteroids suppress aspects of immune function, they can:

increase susceptibility to infections or make existing infections harder to recognize.

Steroids can also suppress fever and other inflammatory signs, potentially masking infection.

Therefore, unexplained fever, persistent cough, worsening wound redness, or other signs of infection should be taken seriously.

10. Why should it not be stopped suddenly?

This is one of the most important points with systemic corticosteroids.

With prolonged or sufficiently intensive corticosteroid treatment, the body's own adrenal glands can reduce their natural cortisol production.

The pathway is approximately:

Steroid treatment → suppression of HPA axis → ↓ endogenous cortisol production

If the steroid is suddenly stopped after significant exposure, the body may not immediately be able to produce enough cortisol.

This can result in adrenal insufficiency.

Therefore:

Do not abruptly discontinue long-term or high-dose deflazacort without medical advice.

A doctor may gradually taper the dose when appropriate.

A short, low-dose course may not always require tapering, but this depends on the actual regimen.

11. Stomach considerations

Deflazacort itself is not identical to an NSAID such as diclofenac, but corticosteroids can contribute to gastrointestinal risk, particularly when combined with NSAIDs.

This is especially relevant to your previous medicines:

Deflazacort + diclofenac

may increase gastrointestinal complications in susceptible patients.

Therefore, this combination should be used only when medically appropriate.

12. Vaccination considerations

Because corticosteroids can suppress immune responses, vaccination planning may need consideration when a person is receiving high-dose or prolonged corticosteroid therapy.

The effect depends on the dose and duration.

A healthcare professional should be informed about ongoing steroid treatment before certain vaccinations.

13. Excipients

The tablet also contains inactive substances, collectively described as excipients q.s.

These are used for:

• tablet formation

• binding

• hardness

• disintegration

• lubrication

• stability

• appearance/coating

The photograph does not show a sufficiently readable ingredient panel to identify the exact excipients and their quantities, so those should not be guessed.

14. Composition summary

DEFZACOTT-6

Active ingredient:

Deflazacort — 6 mg/tablet

Inactive ingredients:
Excipients — q.s.

Drug class:

Systemic glucocorticoid corticosteroid

Main actions:

Anti-inflammatory + immunosuppressive

Key safety issues:

Increased blood glucose, infection risk, blood-pressure/fluid effects, mood/sleep changes, and adrenal suppression with prolonged use.

Most important instruction:

Do not start, increase, or suddenly stop deflazacort without the prescribing clinician's advice, particularly if it has been taken for an extended period.

If you provide a clear photograph of the back/side panel of the Defzacott-6 box, I can also extract the exact printed composition, excipients, manufacturer details, storage instructions, and pack information line by line.